These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11435863)

  • 1. Perineal prostatic cancer seeding following radioactive seed brachytherapy.
    Teh BS; Chou CC; Schwartz MR; Mai WY; Carpenter LS; Butler EB
    J Urol; 2001 Jul; 166(1):212. PubMed ID: 11435863
    [No Abstract]   [Full Text] [Related]  

  • 2. Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome.
    Hinnen KA; Moerland MA; Battermann JJ; van Roermund JG; Monninkhof EM; Jürgenliemk-Schulz IM; van Vulpen M
    Radiother Oncol; 2010 Jul; 96(1):30-3. PubMed ID: 20215039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.
    Crook J; Borg J; Evans A; Toi A; Saibishkumar EP; Fung S; Ma C
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1323-9. PubMed ID: 20675072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer.
    D'Amico AV
    Cancer J; 2001; 7(5):375-6. PubMed ID: 11693895
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer.
    Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Lief JH; Adamovich E
    Am J Clin Oncol; 2008 Dec; 31(6):539-44. PubMed ID: 19060584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
    Walsh PC
    J Urol; 2005 Sep; 174(3):928-9. PubMed ID: 16093990
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
    Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ
    J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
    Nurani R; Wallner K; Merrick G; Virgin J; Orio P; True LD
    J Urol; 2007 Nov; 178(5):1968-73; discussion 1973. PubMed ID: 17868717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma.
    Miller VA; Reuter V; Scher HI
    Urology; 1995 Jul; 46(1):111-3. PubMed ID: 7541581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing assessment of sexual function following permanent prostate brachytherapy for patients with early-stage prostate cancer.
    Stipetich RL; Abel LJ; Blatt HJ; Galbreath RW; Lief JH; Butler WM; Merrick GS
    Clin J Oncol Nurs; 2002; 6(5):271-4. PubMed ID: 12240487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity].
    Pommier P; Delannes M; LeFloch O; Bernier V; Baron MH; Thomas L; Malet C; Bonnet J; Louisot P; Aletti P; Goubard O; Chemin A; Chirat F; Lebivic S; Montbarbon X; Bachaud JM; Votron L; Lasbareilles O; Desmettre O; Bringeon G; Gassa F; Peiffert D
    Cancer Radiother; 2006 Dec; 10(8):559-64. PubMed ID: 16959520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
    Edwards A; Laing R; Langley S
    BJU Int; 2013 Jun; 111(8):1181-2. PubMed ID: 23714643
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer: 7. Radiation therapy for localized disease.
    Warde P; Catton C; Gospodarowicz MK
    CMAJ; 1998 Dec; 159(11):1381-8. PubMed ID: 9861209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.